Early diagnosis featured in Spanish rare diseases plan
This article was originally published in Clinica
Executive Summary
Early diagnosis features in a forthcoming rare diseases plan in Spain. The national strategy is expected to be approved by the so-called "inter-territorial council" of the national health service within the first half of 2009, according to the health ministry. Prevention and early detection/diagnosis of rare diseases constitute one of seven "lines of action" – these also feature a research drive in this area.
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.